Cyclopharm Limited's market cap is currently ―. The company's EPS TTM is AU$-0.05; its P/E ratio is -35.11; and it has a dividend yield of 0.55%. Cyclopharm Limited is scheduled to report earnings on August 21, 2024, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	-	-	-	-	-
EBITDA	-	-	-	-	-
Net Income Common Stockholders	-	-	-	-	-
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	AU$ 20.30M	AU$ 29.25M	AU$ 1.87M	AU$ 12.66M	AU$ 5.85M
Total Assets	AU$ 49.54M	AU$ 55.74M	AU$ 28.28M	AU$ 32.53M	AU$ 23.54M
Total Debt	AU$ 4.33M	AU$ 4.51M	AU$ 4.71M	AU$ 4.92M	AU$ 120.58K
Net Debt	AU$ -15.96M	AU$ -24.74M	AU$ 2.83M	AU$ -7.74M	AU$ -5.73M
Total Liabilities	AU$ 13.01M	AU$ 12.67M	AU$ 11.16M	AU$ 9.32M	AU$ 6.52M
Stockholders Equity	AU$ 36.54M	AU$ 43.07M	AU$ 17.12M	AU$ 23.20M	AU$ 17.02M
Cash Flow	-
Free Cash Flow	-	-	-	-	-
Operating Cash Flow	-	-	-	-	-
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	-	-	-	-	-

Currency in AUD

Cyclopharm Limited Earnings and Revenue History

Income Statement >

Cyclopharm Limited Debt to Assets

Balance Sheet >

Cyclopharm Limited Cash Flow

Cash Flow >

Cyclopharm Limited Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing